Foley R, Owen C, Tabchi S, Razavi G. Panel Discussion: Treatment options for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) patients. Can Hematol Today [Internet]. 2022 Oct. 30 [cited 2024 Apr. 27];1(S10). Available from: https://canadianhematologytoday.com/article/view/29